迪高替尼软膏(Delgocitinib)正品各版本价格

Delgocitinib ointment (Delgocitinib) is a specific treatment drug for atopic dermatitis. The authentic version information and reasonable use methods have attracted much attention. This article will provide practical guidance to patients from the perspectives of different version prices, applicable groups and precautions.

Prices of various versions of genuine Delgocitinib ointment

Currently, Delgocitinib ointment has not yet been approved for marketing in mainland China, and the main circulating version is the original Japanese drug. The drug is available in two specifications: 0.25% concentration, 5 grams per vial, and 0.5% concentration, 5 grams per vial, each box contains 10 vials. The price of 0.25% specification is about US$96/box, and the price of 0.5% specification is about US$130/box.

After purchasing, please pay attention to the storage conditions. Digotinib ointment needs to be stored at room temperature 15-30°C away from light and moisture. It is recommended to use the ointment within 6 months after opening. If the ointment changes color, clumps or has an odor, it should be discontinued immediately. Correct storage methods can maximize drug stability and ensure therapeutic effectiveness.

Who should pay attention when using Delgocitinib ointment?

Different groups of people have specific risks when using Delgocitinib ointment, and the treatment plan needs to be adjusted according to individual conditions.

Pregnant and lactating women

Animal experiments show that the pharmaceutical ingredients of digotinib ointment may penetrate the placental barrier, posing risks to fetal development. Pregnant women should only use it if their doctor assesses that the benefits of treatment outweigh the potential harms. Breastfeeding women need to weigh the priorities of breastfeeding and drug treatment, and suspend breastfeeding if necessary.

Pediatric patients

Children over 2 years old should use Digotinib ointment 0.25% concentration preparation, twice a day, no more than 5 grams per dose. Infants and young children aged 6 months to 2 years old need to reduce the dose by half to 2.5 grams per time. Skin reactions need to be assessed weekly during treatment and long-term use of high-concentration preparations should be avoided.

Elderly patients and those with liver and kidney dysfunction

Although there are no clear contraindications for elderly patients, the dosage needs to be adjusted based on liver and kidney function. For patients with moderate or above liver and kidney dysfunction, it is recommended to reduce the single dose by 20%-30% and extend the dosage interval to once a day.

Special groups need to closely monitor their reactions when taking medication. The following will focus on the precautions for daily use.

Precautions for Delgocitinib Ointment

Standard use of the drug can significantly reduce the incidence of adverse reactions. The following points require special attention from patients.

Avoid contact with specific areas

Do not apply ointment to eyes, oral mucosa or open wounds. In case of accidental contact with eyes, rinse immediately with water for 15 minutes. Damaged skin areas need to be healed before applying medication to prevent excessive absorption of the medication.

Treatment of combined infections

If there is bacterial, fungal or viral infection in the affected area, the infection must be controlled first before using this drug. If redness, swelling and pus appear during treatment, the ointment should be suspended and antibiotic ointment should be applied externally, and use should be resumed after the infection subsides.

In daily care, it is recommended that patients wear pure cotton loose clothing to avoid excessive friction on the affected area. Use a gentle, fragrance-free moisturizer daily to strengthen your skin's barrier function.